Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Otitis Externa D010032 8 associated lipids
Burns D002056 34 associated lipids
Body Weight D001835 333 associated lipids
Peritonitis D010538 38 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Vaginitis D014627 6 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Dermatomycoses D003881 17 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
Aspergillosis D001228 5 associated lipids
Leishmaniasis D007896 19 associated lipids
HIV Seropositivity D006679 15 associated lipids
Influenza, Human D007251 11 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Mycoses D009181 18 associated lipids
Gonorrhea D006069 7 associated lipids
Xerostomia D014987 6 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Urethritis D014526 9 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Blastomycosis D001759 5 associated lipids
Candidemia D058387 2 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Jakab Á et al. Betamethasone augments the antifungal effect of menadione--towards a novel anti-Candida albicans combination therapy. 2015 J. Basic Microbiol. pmid:25707543
Okechukwu DC et al. Evaluation of the anti-candidal activity of methanolic leaf extract of cleistopholis patens (fam. Annonaceae) on candida species isolated from stage II HIV patients. 2015 Afr Health Sci pmid:26957966
Korany MA et al. Application of derivative spectrophotometry under orthogonal polynomial at unequal intervals: determination of metronidazole and nystatin in their pharmaceutical mixture. 2015 Spectrochim Acta A Mol Biomol Spectrosc pmid:25748283
Schulz JC et al. Unfolding and folding internal friction of β-hairpins is smaller than that of α-helices. 2015 J Phys Chem B pmid:25741584
Wang MM et al. Mutagenicity of ZnO nanoparticles in mammalian cells: Role of physicochemical transformations under the aging process. 2015 Nanotoxicology pmid:25676621
Yao JY et al. Evaluation of nystatin isolated from Streptomyces griseus SDX-4 against the ciliate, Ichthyophthirius multifiliis. 2015 Parasitol. Res. pmid:25645004
Moriyama T et al. Caveolae may enable albumin to enter human renal glomerular endothelial cells. 2015 J. Cell. Biochem. pmid:25640083
Semis R et al. Evaluation of antifungal combinations of nystatin-intralipid against Aspergillus terreus using checkerboard and disk diffusion methods. 2015 J Mycol Med pmid:25639922
Martín MJ et al. Development of alginate microspheres as nystatin carriers for oral mucosa drug delivery. 2015 Carbohydr Polym pmid:25498619
Bueno MG et al. Effect of antimicrobial agents incorporated into resilient denture relines on the Candida albicans biofilm. 2015 Oral Dis pmid:24219354